SCHEMBL3883503

SCHEMBL3883503

CCCOc1ccc(CCC(=O)O)cc1-c1ccc2[nH]ccc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.47
LMNA P02545 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
FFAR4 Q5NUL3 5/20 0.43
LTB4R Q15722 2/20 0.43
ENPP2 Q13822 1/20 0.42
GABRA1 P14867 1/20 0.41
GABRB2 P47870 1/20 0.41
RXRA P19793 1/20 0.41
FFAR1 O14842 3/20 0.40
PTGS2 P35354 1/20 0.40
TP53 P04637 1/20 0.39
MDM2 Q00987 1/20 0.39
CCNC P24863 1/20 0.39
CDK8 P49336 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA7 P36544 1/20 0.39
CHRNA10 Q9GZZ6 1/20 0.39
CHRNA9 Q9UGM1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3880517 0.95 RXRA (0.46) S1PR1LMNAL3MBTL1FFAR4LTB4R
SCHEMBL27627121 0.93 RXRA (0.47) S1PR1FFAR4LTB4RENPP2RXRA
SCHEMBL3882870 0.89 FFAR4 (0.45) FFAR4LTB4RENPP2FFAR1
SCHEMBL27607994 0.88 ENPP2 (0.48) FFAR4LTB4RENPP2FFAR1TP53
SCHEMBL3886458 0.88 FFAR4 (0.52) FFAR4LTB4RENPP2FFAR1
SCHEMBL3882776 0.88 FFAR1 (0.49) FFAR4LTB4RENPP2FFAR1TP53
SCHEMBL3882227 0.87 LMNA (0.46) LMNAL3MBTL1FFAR4LTB4RENPP2
SCHEMBL3888319 0.87 FFAR1 (0.48) LMNAL3MBTL1FFAR4LTB4RFFAR1
SCHEMBL3883849 0.87 THRA (0.47) S1PR1FFAR4LTB4RENPP2FFAR1
SCHEMBL3884999 0.87 FFAR1 (0.49) FFAR4LTB4RENPP2FFAR1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP disclosed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US disclosed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP disclosed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof PTGER1, CYSLTR1, PTGS1 S1PR1 77/4885LMNA 820/4885L3MBTL1 1352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.